Cargando…
Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258
BACKGROUND: Prostate cancer is a frequent finding in man. In dogs, malignant disease of the prostate is also of clinical relevance, although it is a less common diagnosis. Even though there are numerous differences in origin and development of the disease, man and dog share many similarities in the...
Autores principales: | Fork, Melani AM, Escobar, Hugo Murua, Soller, Jan T, Sterenczak, Katharina A, Willenbrock, Saskia, Winkler, Susanne, Dorsch, Martina, Reimann-Berg, Nicola, Hedrich, Hans J, Bullerdiek, Jörn, Nolte, Ingo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2527616/ https://www.ncbi.nlm.nih.gov/pubmed/18706092 http://dx.doi.org/10.1186/1471-2407-8-240 |
Ejemplares similares
-
Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl(2)) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer
por: Sterenczak, Katharina A, et al.
Publicado: (2012) -
Genomic characterisation, chromosomal assignment and in vivo localisation of the canine High Mobility Group A1 (HMGA1) gene
por: Beuing, Claudia, et al.
Publicado: (2008) -
Chromosomal assignment of canine THADA gene to CFA 10q25
por: Soller, Jan T, et al.
Publicado: (2008) -
Comparison of non-coding RNAs in human and canine cancer
por: Wagner, Siegfried, et al.
Publicado: (2013) -
Generation and Characterisation of a Canine EGFP-HMGA2 Prostate Cancer In Vitro Model
por: Willenbrock, Saskia, et al.
Publicado: (2014)